Structure Therapeutics
Structure Therapeutics is seeking a strategic and motivated Executive Director, Clinical Compliance to lead clinical compliance and operational readiness across early and late-phase clinical development programs. This role focuses on Phase 3 readiness, inspection planning, and regulatory inspections while establishing scalable, risk-based processes to ensure consistent execution and continuous inspection readiness. The position reports to the Senior Vice President, Clinical Development Operations and partners closely with multiple cross-functional teams to drive compliance and operational excellence.
Headquarters
South San Francisco, California, United States
Company Size
51-200 employees
Founded
2017
Structure Therapeutics is a biopharmaceutical company with the mission 'Medicine is our platform. Accessibility is our cure.' The company is focused on developing medicines with an emphasis on accessibility, and maintains an active pipeline and team as indicated on its website.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Structure Therapeutics.
Director, Clinical and Safety Quality
Alfasigma
Manager of Clinical Quality Assurance
Atea Pharmaceuticals
Senior Manager, Clinical Compliance & Inspection Readiness
Olema Oncology
Director of Clinical Operations Consultant
Clinical Dynamix
Vice President, Clinical Development
Tango Therapeutics
Director, Clinical Quality
Viking Therapeutics